← Eichor
Study identifier: NCT06666790 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

DermaSensor Postmarket Surveillance Study

Condition: Melanoma, Skin  ·  Sponsor: DermaSensor, Inc.

PhaseNA
Planned participants396
Who can joinAll sexes, 40 Years to no upper limit
Healthy volunteersNo

About this study

The objective of this study is to evaluate the sensitivity of the DermaSensor device and Investigators when used on skin lesions concerning for melanoma.

This description comes directly from the study's public registry record.

Talk to the study team

Justin Frazier, MS  ·  508-776-0044  ·  justin.frazier@dermasensor.com

Always discuss trial participation with your own doctor first.

Locations (2)

VelocityNew Smyrna Beach, Florida, United StatesRecruiting
West Clinical ResearchMorehead City, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06666790